Results 181 to 190 of about 1,541,007 (326)

Validation of on-slide immunocytochemistry controls prepared from long-term preserved prefixed cell suspensions. [PDF]

open access: yesCancer Cytopathol
Roque RR   +6 more
europepmc   +1 more source

Catalytic methanol reforming process intensification for integration with proton-exchange membrane fuel cells (PEMFC) - Review

open access: gold
Emilija Todorovski   +6 more
openalex   +1 more source

RoHS‐Compliant, Cu‐Zn‐In‐Se‐Based Core/Multi‐shell Quantum Dots with Efficient and Tunable Short‐Wave Infrared Emission

open access: yesAdvanced Functional Materials, EarlyView.
An innovative combination of size‐controlled template synthesis, partial cation exchange reactions, and dual shell passivation offers a new class of RoHS‐compliant, heavy metal‐free Cu‐Zn‐In‐Se/ZnS/Al2O3 core/shell/shell quantum dots (QDs), exhibiting long‐range tunability, highly efficient SWIR emission with remarkably narrow photoluminescence ...
Avijit Saha   +8 more
wiley   +1 more source

Development of High-Performance Catalytic Ceramic Membrane Microchannel Reactor for Carbon Dioxide Conversion to Methanol. [PDF]

open access: yesMembranes (Basel)
Ullah A   +6 more
europepmc   +1 more source

Methanol [PDF]

open access: yes, 2018
C. Vidal, W.-R. Külpmann
openaire   +1 more source

Upconversion Nanoparticles Embedded Photonic Contact Lens for Transepithelial Corneal Crosslinking Using Hyaluronate – Riboflavin Conjugate

open access: yesAdvanced Functional Materials, EarlyView.
A minimally invasive, transepithelial corneal cross‐linking (TE‐CXL) approach is presented using upconversion nanoparticles (UCNPs)‐loaded contact lenses (UCLs), after topical delivery of hyaluronate–riboflavin conjugates. The NIR‐to‐UV/blue light conversion by UCNPs in a UCL can activate riboflavin for TE‐CXL, resulting in the biomechanical strength ...
Gibum Lee   +8 more
wiley   +1 more source

Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy

open access: yesAdvanced Functional Materials, EarlyView.
A bimetallic Mn–Ca nanoreactor (MCC) is developed as a non‐nucleotide STING nanoagonist for cancer metalloimmunotherapy. MCC induces Ca2+ overload and hydroxyl radical generation, resulting in mitochondrial damage and mtDNA release. The released mtDNA cooperates with Mn2+ to robustly activate cGAS–STING signaling.
Xin Wang Mo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy